000 01480 a2200433 4500
005 20250513051509.0
264 0 _c19940912
008 199409s 0 0 eng d
022 _a0022-2623
024 7 _a10.1021/jm00041a025
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKnoerzer, T A
245 0 0 _aDopaminergic benzo[a]phenanthridines: resolution and pharmacological evaluation of the enantiomers of dihydrexidine, the full efficacy D1 dopamine receptor agonist.
_h[electronic resource]
260 _bJournal of medicinal chemistry
_cJul 1994
300 _a2453-60 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aBenzazepines
_xmetabolism
650 0 4 _aBinding Sites
650 0 4 _aCorpus Striatum
_xmetabolism
650 0 4 _aDopamine Agents
_xchemistry
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aPhenanthridines
_xchemistry
650 0 4 _aRadioligand Assay
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aReceptors, Dopamine D1
_xdrug effects
650 0 4 _aStereoisomerism
650 0 4 _aTransfection
700 1 _aNichols, D E
700 1 _aBrewster, W K
700 1 _aWatts, V J
700 1 _aMottola, D
700 1 _aMailman, R B
773 0 _tJournal of medicinal chemistry
_gvol. 37
_gno. 15
_gp. 2453-60
856 4 0 _uhttps://doi.org/10.1021/jm00041a025
_zAvailable from publisher's website
999 _c7913867
_d7913867